Does the media favor RVMD or ELAN?

In the previous week, Revolution Medicines had 10 more articles in the media than Elanco Animal Health. MarketBeat recorded 21 mentions for Revolution Medicines and 11 mentions for Elanco Animal Health. Elanco Animal Health's average media sentiment score of 0.85 beat Revolution Medicines' score of 0.56 indicating that Elanco Animal Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Revolution Medicines 12 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Elanco Animal Health 5 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer ONC or ELAN?

In the previous week, BeOne Medicines had 5 more articles in the media than Elanco Animal Health. MarketBeat recorded 16 mentions for BeOne Medicines and 11 mentions for Elanco Animal Health. Elanco Animal Health's average media sentiment score of 0.85 beat BeOne Medicines' score of -0.77 indicating that Elanco Animal Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BeOne Medicines 3 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Negative Elanco Animal Health 5 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to ELAN or BNTX?

In the previous week, Elanco Animal Health had 7 more articles in the media than BioNTech. MarketBeat recorded 11 mentions for Elanco Animal Health and 4 mentions for BioNTech. BioNTech's average media sentiment score of 1.21 beat Elanco Animal Health's score of 0.85 indicating that BioNTech is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Elanco Animal Health 5 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive BioNTech 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor ELAN or ROIV?

In the previous week, Roivant Sciences had 1 more articles in the media than Elanco Animal Health. MarketBeat recorded 12 mentions for Roivant Sciences and 11 mentions for Elanco Animal Health. Roivant Sciences' average media sentiment score of 1.50 beat Elanco Animal Health's score of 0.85 indicating that Roivant Sciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Elanco Animal Health 5 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Roivant Sciences 11 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Elanco Animal Health (ELAN) Competitors

$24.21 -0.01 (-0.04%)

Closing price 06/18/2026 03:59 PM Eastern

Extended Trading

$23.63 -0.58 (-2.40%)

As of 06/18/2026 07:40 PM Eastern

Compare

ELAN vs. TEVA, RVMD, ONC, BNTX, and ROIV

Should you buy Elanco Animal Health stock or one of its competitors? MarketBeat compares Elanco Animal Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Elanco Animal Health include Teva Pharmaceutical Industries (TEVA), Revolution Medicines (RVMD), BeOne Medicines (ONC), BioNTech (BNTX), and Roivant Sciences (ROIV). These companies are all part of the "pharmaceutical products" industry.

How does Elanco Animal Health compare to Teva Pharmaceutical Industries?

Teva Pharmaceutical Industries (NYSE:TEVA) and Elanco Animal Health (NYSE:ELAN) are both large-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, institutional ownership, analyst recommendations, risk, valuation, earnings, dividends and media sentiment.

Teva Pharmaceutical Industries presently has a consensus price target of $41.78, suggesting a potential upside of 32.64%. Elanco Animal Health has a consensus price target of $28.55, suggesting a potential upside of 17.91%. Given Teva Pharmaceutical Industries' stronger consensus rating and higher possible upside, research analysts plainly believe Teva Pharmaceutical Industries is more favorable than Elanco Animal Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Teva Pharmaceutical Industries	1 Sell rating(s)	0 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.80
Elanco Animal Health	1 Sell rating(s)	2 Hold rating(s)	10 Buy rating(s)	1 Strong Buy rating(s)	2.79

Teva Pharmaceutical Industries has a net margin of 9.01% compared to Elanco Animal Health's net margin of -4.95%. Teva Pharmaceutical Industries' return on equity of 43.53% beat Elanco Animal Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Teva Pharmaceutical Industries	9.01%	43.53%	8.19%
Elanco Animal Health	-4.95%	7.42%	3.66%

In the previous week, Teva Pharmaceutical Industries had 17 more articles in the media than Elanco Animal Health. MarketBeat recorded 28 mentions for Teva Pharmaceutical Industries and 11 mentions for Elanco Animal Health. Teva Pharmaceutical Industries' average media sentiment score of 1.01 beat Elanco Animal Health's score of 0.85 indicating that Teva Pharmaceutical Industries is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Teva Pharmaceutical Industries	17 Very Positive mention(s)	2 Positive mention(s)	8 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Elanco Animal Health	5 Very Positive mention(s)	3 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

54.1% of Teva Pharmaceutical Industries shares are held by institutional investors. Comparatively, 97.5% of Elanco Animal Health shares are held by institutional investors. 0.5% of Teva Pharmaceutical Industries shares are held by insiders. Comparatively, 1.1% of Elanco Animal Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Teva Pharmaceutical Industries has higher revenue and earnings than Elanco Animal Health. Elanco Animal Health is trading at a lower price-to-earnings ratio than Teva Pharmaceutical Industries, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Teva Pharmaceutical Industries	$17.26B	2.10	$1.41B	$1.33	23.68
Elanco Animal Health	$4.72B	2.56	-$232M	-$0.50	N/A

Teva Pharmaceutical Industries has a beta of 0.84, suggesting that its share price is 16% less volatile than the broader market. Comparatively, Elanco Animal Health has a beta of 1.69, suggesting that its share price is 69% more volatile than the broader market.

Summary

Teva Pharmaceutical Industries beats Elanco Animal Health on 11 of the 17 factors compared between the two stocks.

How does Elanco Animal Health compare to Revolution Medicines?

Revolution Medicines (NASDAQ:RVMD) and Elanco Animal Health (NYSE:ELAN) are both large-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, risk, earnings, analyst recommendations, institutional ownership, profitability, valuation and dividends.

Revolution Medicines presently has a consensus target price of $123.72, suggesting a potential downside of 24.09%. Elanco Animal Health has a consensus target price of $28.55, suggesting a potential upside of 17.91%. Given Elanco Animal Health's higher probable upside, analysts plainly believe Elanco Animal Health is more favorable than Revolution Medicines.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Revolution Medicines	1 Sell rating(s)	1 Hold rating(s)	17 Buy rating(s)	3 Strong Buy rating(s)	3.00
Elanco Animal Health	1 Sell rating(s)	2 Hold rating(s)	10 Buy rating(s)	1 Strong Buy rating(s)	2.79

Revolution Medicines has a net margin of 0.00% compared to Elanco Animal Health's net margin of -4.95%. Elanco Animal Health's return on equity of 7.42% beat Revolution Medicines' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Revolution Medicines	N/A	-83.22%	-59.06%
Elanco Animal Health	-4.95%	7.42%	3.66%

In the previous week, Revolution Medicines had 10 more articles in the media than Elanco Animal Health. MarketBeat recorded 21 mentions for Revolution Medicines and 11 mentions for Elanco Animal Health. Elanco Animal Health's average media sentiment score of 0.85 beat Revolution Medicines' score of 0.56 indicating that Elanco Animal Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Revolution Medicines	12 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Elanco Animal Health	5 Very Positive mention(s)	3 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Elanco Animal Health has higher revenue and earnings than Revolution Medicines. Elanco Animal Health is trading at a lower price-to-earnings ratio than Revolution Medicines, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Revolution Medicines	$11.58M	2,992.37	-$1.13B	-$7.07	N/A
Elanco Animal Health	$4.72B	2.56	-$232M	-$0.50	N/A

94.3% of Revolution Medicines shares are owned by institutional investors. Comparatively, 97.5% of Elanco Animal Health shares are owned by institutional investors. 7.6% of Revolution Medicines shares are owned by company insiders. Comparatively, 1.1% of Elanco Animal Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Revolution Medicines has a beta of 1.4, meaning that its stock price is 40% more volatile than the broader market. Comparatively, Elanco Animal Health has a beta of 1.69, meaning that its stock price is 69% more volatile than the broader market.

Summary

Elanco Animal Health beats Revolution Medicines on 9 of the 17 factors compared between the two stocks.

How does Elanco Animal Health compare to BeOne Medicines?

BeOne Medicines (NASDAQ:ONC) and Elanco Animal Health (NYSE:ELAN) are both large-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, institutional ownership, valuation, earnings, risk, profitability and dividends.

BeOne Medicines has higher revenue and earnings than Elanco Animal Health. Elanco Animal Health is trading at a lower price-to-earnings ratio than BeOne Medicines, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BeOne Medicines	$5.34B	5.55	$286.93M	$4.47	60.44
Elanco Animal Health	$4.72B	2.56	-$232M	-$0.50	N/A

BeOne Medicines currently has a consensus price target of $390.00, indicating a potential upside of 44.36%. Elanco Animal Health has a consensus price target of $28.55, indicating a potential upside of 17.91%. Given BeOne Medicines' stronger consensus rating and higher probable upside, equities research analysts plainly believe BeOne Medicines is more favorable than Elanco Animal Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BeOne Medicines	1 Sell rating(s)	1 Hold rating(s)	11 Buy rating(s)	2 Strong Buy rating(s)	2.93
Elanco Animal Health	1 Sell rating(s)	2 Hold rating(s)	10 Buy rating(s)	1 Strong Buy rating(s)	2.79

48.6% of BeOne Medicines shares are owned by institutional investors. Comparatively, 97.5% of Elanco Animal Health shares are owned by institutional investors. 6.2% of BeOne Medicines shares are owned by insiders. Comparatively, 1.1% of Elanco Animal Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

BeOne Medicines has a beta of 0.49, indicating that its share price is 51% less volatile than the broader market. Comparatively, Elanco Animal Health has a beta of 1.69, indicating that its share price is 69% more volatile than the broader market.

In the previous week, BeOne Medicines had 5 more articles in the media than Elanco Animal Health. MarketBeat recorded 16 mentions for BeOne Medicines and 11 mentions for Elanco Animal Health. Elanco Animal Health's average media sentiment score of 0.85 beat BeOne Medicines' score of -0.77 indicating that Elanco Animal Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
BeOne Medicines	3 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Negative
Elanco Animal Health	5 Very Positive mention(s)	3 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

BeOne Medicines has a net margin of 8.94% compared to Elanco Animal Health's net margin of -4.95%. BeOne Medicines' return on equity of 12.06% beat Elanco Animal Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BeOne Medicines	8.94%	12.06%	6.69%
Elanco Animal Health	-4.95%	7.42%	3.66%

Summary

BeOne Medicines beats Elanco Animal Health on 14 of the 17 factors compared between the two stocks.

How does Elanco Animal Health compare to BioNTech?

Elanco Animal Health (NYSE:ELAN) and BioNTech (NASDAQ:BNTX) are both large-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, valuation, profitability, institutional ownership, earnings and analyst recommendations.

In the previous week, Elanco Animal Health had 7 more articles in the media than BioNTech. MarketBeat recorded 11 mentions for Elanco Animal Health and 4 mentions for BioNTech. BioNTech's average media sentiment score of 1.21 beat Elanco Animal Health's score of 0.85 indicating that BioNTech is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Elanco Animal Health	5 Very Positive mention(s)	3 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
BioNTech	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Elanco Animal Health has a net margin of -4.95% compared to BioNTech's net margin of -44.39%. Elanco Animal Health's return on equity of 7.42% beat BioNTech's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Elanco Animal Health	-4.95%	7.42%	3.66%
BioNTech	-44.39%	-5.30%	-4.62%

Elanco Animal Health has higher revenue and earnings than BioNTech. Elanco Animal Health is trading at a lower price-to-earnings ratio than BioNTech, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Elanco Animal Health	$4.72B	2.56	-$232M	-$0.50	N/A
BioNTech	$3.25B	7.08	-$1.29B	-$5.88	N/A

Elanco Animal Health has a beta of 1.69, meaning that its share price is 69% more volatile than the broader market. Comparatively, BioNTech has a beta of 1.32, meaning that its share price is 32% more volatile than the broader market.

Elanco Animal Health currently has a consensus target price of $28.55, indicating a potential upside of 17.91%. BioNTech has a consensus target price of $129.56, indicating a potential upside of 42.55%. Given BioNTech's higher possible upside, analysts clearly believe BioNTech is more favorable than Elanco Animal Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Elanco Animal Health	1 Sell rating(s)	2 Hold rating(s)	10 Buy rating(s)	1 Strong Buy rating(s)	2.79
BioNTech	1 Sell rating(s)	4 Hold rating(s)	13 Buy rating(s)	1 Strong Buy rating(s)	2.74

97.5% of Elanco Animal Health shares are owned by institutional investors. Comparatively, 15.5% of BioNTech shares are owned by institutional investors. 1.1% of Elanco Animal Health shares are owned by insiders. Comparatively, 19.2% of BioNTech shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Elanco Animal Health beats BioNTech on 10 of the 16 factors compared between the two stocks.

How does Elanco Animal Health compare to Roivant Sciences?

Elanco Animal Health (NYSE:ELAN) and Roivant Sciences (NASDAQ:ROIV) are both large-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, media sentiment, dividends, valuation, analyst recommendations, institutional ownership, risk and profitability.

Elanco Animal Health has a beta of 1.69, indicating that its stock price is 69% more volatile than the broader market. Comparatively, Roivant Sciences has a beta of 1.13, indicating that its stock price is 13% more volatile than the broader market.

97.5% of Elanco Animal Health shares are owned by institutional investors. Comparatively, 64.8% of Roivant Sciences shares are owned by institutional investors. 1.1% of Elanco Animal Health shares are owned by company insiders. Comparatively, 10.8% of Roivant Sciences shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Roivant Sciences had 1 more articles in the media than Elanco Animal Health. MarketBeat recorded 12 mentions for Roivant Sciences and 11 mentions for Elanco Animal Health. Roivant Sciences' average media sentiment score of 1.50 beat Elanco Animal Health's score of 0.85 indicating that Roivant Sciences is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Elanco Animal Health	5 Very Positive mention(s)	3 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Roivant Sciences	11 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Elanco Animal Health currently has a consensus target price of $28.55, indicating a potential upside of 17.91%. Roivant Sciences has a consensus target price of $33.59, indicating a potential upside of 6.88%. Given Elanco Animal Health's stronger consensus rating and higher possible upside, equities analysts clearly believe Elanco Animal Health is more favorable than Roivant Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Elanco Animal Health	1 Sell rating(s)	2 Hold rating(s)	10 Buy rating(s)	1 Strong Buy rating(s)	2.79
Roivant Sciences	1 Sell rating(s)	1 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.75

Elanco Animal Health has a net margin of -4.95% compared to Roivant Sciences' net margin of -3,629.19%. Elanco Animal Health's return on equity of 7.42% beat Roivant Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Elanco Animal Health	-4.95%	7.42%	3.66%
Roivant Sciences	-3,629.19%	-20.54%	-19.43%

Elanco Animal Health has higher revenue and earnings than Roivant Sciences. Roivant Sciences is trading at a lower price-to-earnings ratio than Elanco Animal Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Elanco Animal Health	$4.72B	2.56	-$232M	-$0.50	N/A
Roivant Sciences	$8.26M	2,736.88	-$299.77M	-$0.60	N/A

Summary

Elanco Animal Health beats Roivant Sciences on 12 of the 16 factors compared between the two stocks.

Get Elanco Animal Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ELAN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ELAN vs. The Competition

Export

Metric	Elanco Animal Health	MED Industry	Medical Sector	NYSE Exchange
Market Cap	$12.10B	$5.71B	$6.43B	$23.21B
Dividend Yield	N/A	1.56%	2.68%	4.06%
P/E Ratio	-48.42	35.52	24.75	31.61
Price / Sales	2.56	22.91	529.99	112.15
Price / Cash	10.44	16.85	45.07	24.44
Price / Book	1.84	3.19	10.80	4.68
Net Income	-$232M	$218.81M	$3.57B	$1.08B
7 Day Performance	0.07%	1.04%	0.72%	-0.82%
1 Month Performance	13.64%	0.55%	0.41%	1.07%
1 Year Performance	79.81%	16.97%	29.34%	25.02%

Elanco Animal Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ELAN Elanco Animal Health	3.7679 of 5 stars	$24.21 0.0%	$28.55 +17.9%	+79.8%	$12.10B	$4.72B	N/A	9,400	News Coverage Positive News Analyst Forecast Gap Up
TEVA Teva Pharmaceutical Industries	4.7751 of 5 stars	$33.66 -2.8%	$41.78 +24.1%	+85.6%	$39.82B	$17.26B	25.30	33,950	Trending News Insider Trade
RVMD Revolution Medicines	1.6734 of 5 stars	$160.06 +4.0%	$123.72 -22.7%	+311.0%	$32.71B	$11.58M	N/A	250	News Coverage Positive News Insider Trade
ONC BeOne Medicines	4.0608 of 5 stars	$268.20 +1.4%	$390.00 +45.4%	+9.3%	$29.02B	$5.34B	60.00	12,000	Analyst Downgrade Insider Trade
BNTX BioNTech	4.5484 of 5 stars	$90.80 +0.3%	$129.56 +42.7%	-14.7%	$22.90B	$3.25B	N/A	7,807	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:ELAN) was last updated on 6/21/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Elanco Animal Health (ELAN) Competitors

ELAN vs. TEVA, RVMD, ONC, BNTX, and ROIV

How does Elanco Animal Health compare to Teva Pharmaceutical Industries?

Summary

How does Elanco Animal Health compare to Revolution Medicines?

Summary

How does Elanco Animal Health compare to BeOne Medicines?

Summary

How does Elanco Animal Health compare to BioNTech?

Summary

How does Elanco Animal Health compare to Roivant Sciences?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ELAN vs. The Competition

Elanco Animal Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Elanco Animal Health (ELAN) Competitors

ELAN vs. TEVA, RVMD, ONC, BNTX, and ROIV

How does Elanco Animal Health compare to Teva Pharmaceutical Industries?

Do analysts recommend TEVA or ELAN?

Is TEVA or ELAN more profitable?

Does the media favor TEVA or ELAN?

Do institutionals and insiders have more ownership in TEVA or ELAN?

Which has stronger valuation & earnings, TEVA or ELAN?

Which has more risk and volatility, TEVA or ELAN?

Summary

How does Elanco Animal Health compare to Revolution Medicines?

Do analysts prefer RVMD or ELAN?

Is RVMD or ELAN more profitable?

Does the media favor RVMD or ELAN?

Which has stronger earnings & valuation, RVMD or ELAN?

Do institutionals & insiders have more ownership in RVMD or ELAN?

Which has more volatility & risk, RVMD or ELAN?

Summary

How does Elanco Animal Health compare to BeOne Medicines?

Which has stronger valuation and earnings, ONC or ELAN?

Do analysts recommend ONC or ELAN?

Do institutionals and insiders believe in ONC or ELAN?

Which has more volatility & risk, ONC or ELAN?

Does the media prefer ONC or ELAN?

Is ONC or ELAN more profitable?

Summary

How does Elanco Animal Health compare to BioNTech?

Does the media refer more to ELAN or BNTX?

Is ELAN or BNTX more profitable?

Which has preferable valuation and earnings, ELAN or BNTX?

Which has more volatility and risk, ELAN or BNTX?

Do analysts recommend ELAN or BNTX?

Do institutionals & insiders believe in ELAN or BNTX?

Summary

How does Elanco Animal Health compare to Roivant Sciences?

Which has more risk and volatility, ELAN or ROIV?

Do insiders & institutionals hold more shares of ELAN or ROIV?

Does the media favor ELAN or ROIV?

Do analysts rate ELAN or ROIV?

Is ELAN or ROIV more profitable?

Which has stronger earnings and valuation, ELAN or ROIV?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ELAN vs. The Competition

Elanco Animal Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools